[Skip to Content]
[Skip to Content Landing]
November 16, 1907


JAMA. 1907;XLIX(20):1676-1677. doi:10.1001/jama.1907.02530200034005

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


In this week's issue, under the head of Correspondence, we publish some notes from a correspondent on the status of pharmacology abroad which show the changed conditions there. The attitude of Ehrlich and others in Germany, as described by our correspondent, shows a strong conviction that much more is to be expected from the investigation of drugs; in fact, that their systematic study has scarcely begun, whereas many of those who have devoted so much time to the study of antitoxins, etc., admit that the prospects for advancement along these lines are at present not very bright.

Without wishing to belittle in the least the immense value of bacteriologic work in connection with the discovery of new remedies, and recognizing how much more may be expected of this line of investigation (especially in the most important branch of medicine—prevention), it is still true that in the treatment of disease, whether

First Page Preview View Large
First page PDF preview
First page PDF preview